Study to Assess the Safety, Tolerability and Pharmacokinetics of STI-1558 in Healthy Volunteers

NCT05364840 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

DRUG: STI-1558
DRUG: Placebo

Sponsor

Sorrento Therapeutics, Inc.